| Literature DB >> 36226194 |
Xupeng Li1, Yanbin Bai1, Jingsheng Li1, Zongchang Chen1, Yong Ma1, Bingang Shi1, Xiangmin Han1, Yuzhu Luo1, Jiang Hu1, Jiqing Wang1, Xiu Liu1, Shaobin Li1, Zhidong Zhao1.
Abstract
Long-chain fatty acyl-CoA synthase 1 (ACSL1) plays a vital role in the synthesis and metabolism of fatty acids. The proportion of highly unsaturated fatty acids in beef not only affects the flavor and improves the meat's nutritional value. In this study, si-ACSL1 and NC-ACSL1 were transfected in bovine preadipocytes, respectively, collected cells were isolated on the fourth day of induction, and then RNA-Seq technology was used to screen miRNAs related to unsaturated fatty acid synthesis. A total of 1,075 miRNAs were characterized as differentially expressed miRNAs (DE-miRNAs), of which the expressions of 16 miRNAs were upregulated, and that of 12 were downregulated. Gene ontology analysis indicated that the target genes of DE-miRNAs were mainly involved in biological regulation and metabolic processes. Additionally, KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis identified that the target genes of DE-miRNAs were mainly enriched in metabolic pathways, fatty acid metabolism, PI3K-Akt signaling pathway, glycerophospholipid metabolism, fatty acid elongation, and glucagon signaling pathway. Combined with the previous mRNA sequencing results, several key miRNA-mRNA targeting relationship pairs, i.e., novel-m0035-5p-ACSL1, novel-m0035-5p-ELOVL4, miR-9-X-ACSL1, bta-miR-677-ACSL1, miR-129-X-ELOVL4, and bta-miR-485-FADS2 were screened via the miRNA-mRNA interaction network. Thus, the results of this study provide a theoretical basis for further research on miRNA regulation of unsaturated fatty acid synthesis in bovine adipocytes.Entities:
Keywords: ACSL1; RNA-seq; bovine adipocytes; micrornas; unsaturated fatty acids
Year: 2022 PMID: 36226194 PMCID: PMC9548527 DOI: 10.3389/fgene.2022.994806
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.772
Overview of small RNA sequencing.
| Id | clean_reads | high_quality | 3’adapter_null | insert_null | 5’adapter_contaminants | polyA | clean_tags |
|---|---|---|---|---|---|---|---|
| NC-1 | 11,655,387 (100%) | 11,568,102 (99.2511%) | 26,054 (0.2252%) | 49,674 (0.4294%) | 14,982 (0.1295%) | 103 (0.0009%) | 10,986,690 (94.2628%) |
| NC-2 | 11,231,395 (100%) | 11,097,944 (98.8118%) | 59,021 (0.5318%) | 4,456 (0.0402%) | 3,871 (0.0349%) | 112 (0.0010%) | 10,857,341 (96.6696%) |
| NC-3 | 11,219,898 (100%) | 11,079,983 (98.7530%) | 33,458 (0.3020%) | 8,190 (0.0739%) | 7,796 (0.0704%) | 110 (0.0010%) | 10,692,844 (95.3025%) |
| si-1 | 11,463,101 (100%) | 11,357,344 (99.0774%) | 25,051 (0.2206%) | 96,814 (0.8524%) | 21,465 (0.1890%) | 145 (0.0013%) | 1,0,491,794 (91.5267%) |
| si-2 | 12,463,501 (100%) | 1,2,301,997 (98.7042%) | 48,443 (0.3938%) | 6,041 (0.0491%) | 4,318 (0.0351%) | 125 (0.0010%) | 12,072,144 (96.8600%) |
| si-3 | 11,680,612 (100%) | 11,550,211 (98.8836%) | 58,475 (0.5063%) | 4,189 (0.0363%) | 3,364 (0.0291%) | 84 (0.0007%) | 11,344,492 (97.1224%) |
FIGURE 1Correlation analysis of small RNA sequencing data. (A) Statistical analysis of small RNA fragment size. (B) Statistical analysis of the types of small RNA fragments after comparison with the database, including miRNA (existing miRNAs, known miRNAs and novel miRNAs), rRNA, scRNA, snRNA, snoRNA, tRNA, exon sense, miRNA editing, other genome, and unann.
FIGURE 2Statistical analysis of DE-miRNA. (A) The expression of miRNA volcano. The green dots on the left represent miRNAs that are significantly downregulated; the blue dots represent miRNAs that were not significantly different; and the red dots on the right represent miRNAs that were significantly upregulated. (B) Cluster map of differentially expressed miRNAs. Red indicates elevated expression and green indicates downregulated expression.
FIGURE 3Functional enrichment analysis of DE-miRNAs. (A) GO enrichment analysis of target genes of DE-miRNAs. (B) Top 20 KEGG signaling pathways enriched by DE-miRNAs target genes.
FIGURE 4Validation of the miRNA-Seq results. The qRT-PCR validation was performed on 10 DE-miRNAs. These data show the mean ± SD for three replicates. Error bars indicate the standard deviation.
FIGURE 5Interaction network of DE-miRNAs. (A) Network analysis of DE-miRNA target genes and their enrichment pathways. Red shows the upregulated mRNA. Green represents downregulated mRNA, and yellow represents the enriched signaling pathways. (B) Co-expression network of DE-miRNA and its target genes. Red is the miRNA whose expression is upregulated. Green represents downregulated miRNA, and blue represents mRNA.
Nine significantly enriched pathways related to lipid metabolism.
| Pathyway ID | Pathyway term | Qvalue | Target gene list |
|---|---|---|---|
| ko04151 | PI3K-Akt signaling pathway | 2.39E-02 | ANGPT2,COL1A2,COL9A1,FGFR1,PRKAA1,CDKN1A,FGF2,PRLR,COL4A1,COL4A5,LPAR1,CD19,MAPK3 |
| COL6A1,GNB3,LPAR5,FGFR2,G6PC,ITGA6,COL6A5,LPAR2,PPP2R1A,PPP2R2C,CREB1,THBS1 | |||
| ko04010 | MAPK signaling pathway | 3.07E-08 | ANGPT2,FGF18,MAP3K1,DUSP2,FGFR1,IKBKB, TGFB2,TEK,MAPK14,PPP3CB,DUSP10,FGF2,NF1,AKT3 |
| NLK,SRF,MAPK8,EFNA4,CACNB3,MET,RRAS2,TNF,IL1A,MAP3K4,AKT1,FAS | |||
| ko04152 | AMPK signaling pathway | 1.89E-04 | PPP2CB,EIF4EBP1,SIRT1,PFKFB2,PRKAA1,CD36,AKT3,MAP3K7,CREB5,ADRA1A,SREBF1,ADIPOR2 |
| PPARGC1A,PPP2R1A,FASN,SCD5,CREB1,CCND1,HMGCR | |||
| ko00062 | Fatty acid elongation | 4.12E-02 | ELOVL4,HACD4,ELOVL5,PPT2,HACD2,ACOT7,HSD17B12,HADHB, HADHA,ECHS1,ELOVL6,ELOVL1,HADH |
| PPT1,HACD3,ACOT4 | |||
| ko01212 | Fatty acid metabolism | 5.31E-03 | ACSL1,HSD17B8,CBR4,ELOVL4,HACD4,ELOVL5,HACD2,EHHADH, ACADS,ACAT2,HADHB, ACADM,ELOV6 |
| MCAT, FASN,SCD5,FADS1,FADS2,ACADL,HSD17B4,HACD3 | |||
| ko00564 | Glycerophospholipid metabolism | 4.12E-02 | GNPAT, AGPAT5,ETNK2,PLPP1,DGKE, GPAT4,DGKB,GPD1,AGPAT1,PCYT1A,PLA2G15,PLD1,DGKA, PISD |
| PLA2G4A,PLD3,LPGAT1,GPAM,PLA2G12A,DGKD, LPIN3,GPAT3 | |||
| ko04911 | Insulin secretion | 4.25E-02 | CAMK2G,ATP1A2,FXYD2,ADCY7,ADCY6,ADCYAP1R1,CREB5,KCNMB4,GCK,VAMP2,SLC2A2,CREB3L1 |
| CACNA1F,PRKACB, PRKCB,KCNN4,CAMK2D,STX1A,SLC2A1 | |||
| ko04922 | Glucagon signaling pathway | 4.12E-02 | SIRT1,PRKAA1,PPP3CB,SIK2,CAMK2G,PRKAG1,GCK,PPP3CC,SLC2A2,PRKACB, PHKG1,CALM3,SLC2A1 |
| PPARGC1A,CPT1B,CREB1,ITPR1,PKM,CALM1 | |||
| ko04146 | Peroxisome | 3.51E-02 | GNPAT, ACSL1,PEX1,PEX11A,IDH2,NUDT7,PEX19,PEX12,CROT,PEX6,DDO,ABCD1,FAR1,PEX7,DECR2 |
| PEX10,EHHADH,MVK,ABCD3, SLC25A17,ABCD4 |